Deepak Nagrath

20PUBLICATIONS
169CO-AUTHORS
Molecular targetsNanomedicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Reaction engineering (excl. nuclear reactions)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 24, 2026
Microenvironment-derived acetylated amino acids promote glioblastoma treatment resistance.

|Aug 10, 2026
Oral nano-delivery of a gut microbial metabolite enhances T cell stemness for cancer immunotherapy.

|Apr 28, 2026
Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancer.

|Feb 04, 2026
ZFTA-RELA ependymomas make itaconate to epigenetically drive fusion expression.

Siva Kumar Natarajan, Joanna Lum, James Haggerty Skeans

|Feb 02, 2026
Integrative Analysis of Multiomic Pathways Predicts Cancer-Affected Lobes in Lung Cancer.

Frank Weinberg, Abhinav Achreja, Amrita Roy

|Dec 28, 2025
BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity.

Wang Gong, Hülya F Taner, Yuesong Wu

Pageof 4

Frequent Collaborators

11 joint publications

Olamide Animasahun

8 joint publications

Abhinav Achreja

4 joint publications

James J Moon

4 joint publications

Anjali Mittal